Whereas a few large studies find a similar prevalence of antineuronal antibodies in patients with
psychotic disorders, other psychiatric disorders and healthy controls, 1 2 there is some evidence of an increased prevalence of N - methyl - D - aspartate receptor (NMDAR) antibodies in patients with
first -
episode psychosis.3 4 In their present study, the authors aimed to (1) investigate the prevalence of neuronal cell surface antibodies in patients with
first -
episode psychosis and healthy controls and (2) compare the clinical and cognitive profile of patient's with and without these antibodies.